The world is in a constant evolution. This evolution has an impact on the way consumers consider products or services. These changes also concern the science.
Gnosis by lesaffre as pioneer in innovation
- Innovate better and faster
- Adapt our science to be more and more sustainable
- Mimic as close as possible human model in preclinical stage
- Develop new analytical methods
To innovate better and faster, we want to develop models that can be suitable for different ingredients or molecules. Using the same model for different ingredient will allow scientific to save time.
To improve the sustainability of science, Gnosis by Lesaffre develops models without animal. Indeed, animal models present lack of translation to clinical study.
Some models are not predictive in human as they are too far for human model in preclinical stage. For example, 2D cell line cultures are too simplistic and not react to a relevant manner compared to human. Some other models such as organoid suspension culture are not suitable to investigate on molecules or ingredients properties such as probiotics.
The intestine-chip revolutionizes the world of in-vitro models
- A top channel that represents the lumen of the intestine. In this part, the epithelium cells are organized like in human with the villosities on the top. As the organization is like in human, the tight junctions between epithelial cells are located as the same place in human.
- A bottom channel presenting some endothelial cells. These endothelial cells present a blood vessel organization.
- A porous membrane between the top and bottom channels. This porous membrane allows the exchange between the two channels as it happens in the human body.
Latest news & videos
- Clinical studies
- Digestion & Gut Health
- Infographic
- Mar 29, 2024
S.boulardii CNCMI-3799: The Clinical Study Dedicated to Children’s Gut Health
Every year, millions of children worldwide suffer from diarrhea and are at risk of...
- Adonat
- Mood & Cognitive Health
- News
- Mar 27, 2024
SAMe Holds Promise for Depression: 2 New Papers
A new systematic review and meta-analysis highlight SAMe as a potential supplemental therapy for...
- Adonat
- Digestion & Gut Health
- Leaflet
- Mar 25, 2024
Adonat® Premium SAMe Showcased at Nutraceuticals Europe Summit & Expo 2024: «Investing in Well-being and Longevity»
Gnosis by Lesaffre participated in Spain’s foremost trade event, the Nutraceuticals Europe Summit &...